• TransMedics Group director James R. Tobin sold 4,059 shares of common stock on Nov. 9, 2026.
• The sales comprised 59 shares at $93.96 each and 4,000 shares at $94.98 each.
• Following the transactions, Tobin held 2,922 shares directly and 155,146 shares indirectly through the James R. Tobin 2012 Trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-458437), on November 12, 2026, and is solely responsible for the information contained therein.